4//SEC Filing
Friedland Jeffrey 4
Accession 0001214659-17-007033
CIK 0001625288other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 2:54 PM ET
Size
15.8 KB
Accession
0001214659-17-007033
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Other
Common Stock
2017-11-29+130,859→ 208,000 total(indirect: By LLC) - Other
Class C Warrants (right to buy)
2017-11-29+20,800→ 20,800 total(indirect: By LLC)Exercise: $0.50From: 2017-11-29Exp: 2018-07-14→ Common Stock (20,800 underlying) - Other
Class B Warrants (right to buy)
2017-11-29+20,800→ 20,800 total(indirect: By LLC)Exercise: $0.38From: 2017-11-29Exp: 2018-05-07→ Common Stock (20,800 underlying) - Other
Common Stock
2017-11-29+15,099,083→ 24,000,000 total(indirect: By Intiva USA Inc.) - Other
Common Stock
2017-11-29+1,258,257→ 2,000,000 total - Other
Class A Warrants (right to buy)
2017-11-29+20,800→ 20,800 total(indirect: By LLC)Exercise: $0.25From: 2017-11-29Exp: 2018-01-31→ Common Stock (20,800 underlying)
Footnotes (7)
- [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
- [F2]Acquired in exchange for all of Intiva USA's shares of Intiva BioPharma Inc.
- [F3]Acquired in exchange for all of Jeffrey Friedland's shares of Intiva BioPharma Inc.
- [F4]Acquired in exchange for all of Lane 6552 LLC's shares of Intiva BioPharma Inc.
- [F5]Acquired in exchange for all of Lane 6552 LLC's Class A warrants of Intiva BioPharma Inc.
- [F6]Acquired in exchange for all of Lane 6552 LLC's Class B warrants of Intiva BioPharma Inc.
- [F7]Acquired in exchange for all of Lane 6552 LLC's Class C warrants of Intiva BioPharma Inc.
Documents
Issuer
Intiva BioPharma Inc.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001579962
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 2:54 PM ET
- Size
- 15.8 KB